Frederic H. Moll - 10 Feb 2025 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Role
Director
Signature
/s/ Jonathan Stone, Attorney-in-Fact for Frederic Moll
Issuer symbol
PRCT
Transactions as of
10 Feb 2025
Net transactions value
+$40,102
Form type
4
Filing time
12 Feb 2025, 17:39:47 UTC
Previous filing
10 Jan 2025
Next filing
24 Feb 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRCT Common Stock Options Exercise $35,576 +26,749 +3.3% $1.33 836,358 10 Feb 2025 Direct
transaction PRCT Common Stock Options Exercise $4,526 +5,263 +0.63% $0.8600 841,621 10 Feb 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -26,749 -100% $0.000000 0 10 Feb 2025 Common Stock 26,749 $1.33 Direct F1
transaction PRCT Stock Option (Right to Buy) Options Exercise $0 -5,263 -100% $0.000000 0 10 Feb 2025 Common Stock 5,263 $0.8600 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock option is fully vested and exercisable.